| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
|---|---|---|---|---|---|---|
| 2018 | 2-anilino-4-amino-5-aroylthiazole-type compound AS7128 inhibits lung cancer growth through decreased iASPP and p53 interaction | Cheng H.-W.; Chein R.-J.; Cheng T.-J.; Wu P.-S.; Wu H.-Y.; Hung P.-F.; Wang C.-J.; Hsu Y.-L.; Wong J.-M.; ANG YUAN ; Wong C.-H.; PAN-CHYR YANG ; SZU-HUA PAN | Cancer Science | 3 | 2 | |
| 2018 | Accuracy of a Nutrient Database in Estimating the Dietary Phosphorus-to-Protein Ratio and Using a Boiling Method in Low-Phosphate Hospital Diets | Tsai W.-C.; Peng Y.-S.; Wu H.-Y.; Hsu S.-P.; Chiu Y.-L.; Liu L.-C.; Tsai S.-M.; KUO-LIONG CHIEN | Scientific Reports | 8 | 8 | |
| 2021 | Acute effects of dietary phosphorus intake on markers of mineral metabolism in hemodialysis patients: post hoc analysis of a randomized crossover trial | Tsai W.-C.; Wu H.-Y.; Chiu Y.-L.; Yang J.-Y.; Pai M.-F.; Wu Y.-R.; WAN-YU LIN ; KUAN-YU HUNG ; KUO-LIONG CHIEN ; Hsu S.-P.; Peng Y.-S. | Renal Failure | 2 | 0 | |
| 2018 | Age modifies the risk factor profiles for acute kidney injury among recently diagnosed type 2 diabetic patients: a population-based study | CHIA-TER CHAO ; Wang J.; Wu H.-Y.; JENQ-WEN HUANG ; KUO-LIONG CHIEN | GeroScience | 33 | 31 | |
| 2011 | Antibodies against Helicobacter pylori heat shock protein 60 aggravate HSP60-mediated proinflammatory responses | Liao K.-W.; Lin C.-S.; Chen W.-L.; Yang C.-T.; Lin C.-M.; Hsu W.-T.; Lin Y.-Y.; Chiu Y.-H.; Huang K.-C.; Wu H.-Y.; MING-SHIANG WU ; Wu C.-J.; Mao S.J.T.; Tsai N.-M. | Cytokine | 9 | 6 | |
| 2017 | Association of intensive blood pressure control and kidney disease progression in nondiabetic patients with chronic kidney disease: A systematic review and meta-analysis | Tsai W.-C.; Wu H.-Y.; Peng Y.-S.; Yang J.-Y.; Chen H.-Y.; Chiu Y.-L.; Hsu S.-P.; Ko M.-J.; Pai M.-F.; YU-KANG TU ; KUAN-YU HUNG ; KUO-LIONG CHIEN | JAMA Internal Medicine | 85 | 76 | |
| 2013 | C/EBP homologous protein deficiency aggravates acute pancreatitis and associated lung injury | TE-I WENG ; Wu H.-Y.; Chen B.-L.; Jhuang J.-Y.; KUO-HOW HUANG ; CHIH-KANG CHIANG ; Liu S.-H. | World Journal of Gastroenterology | 7 | 8 | |
| 2018 | C1GALT1 predicts poor prognosis and is a potential therapeutic target in head and neck cancer | MEI-CHUN LIN ; Chien P.-H.; Wu H.-Y.; Chen S.-T.; Juan H.-F. ; PEI-JEN LOU ; MIN-CHUAN HUANG | Oncogene | 41 | 43 | |
| 2022 | Cardioprotective effects of dipeptidyl peptidase-4 inhibitors versus sulfonylureas in addition to metformin: A nationwide cohort study of patients with type 2 diabetes | Wang J.; Wu H.-Y.; KUO-LIONG CHIEN | Diabetes and Metabolism | 7 | 1 | |
| 2016 | Chinese fermented meat products | Chen M.-J.; Tu R.-J.; Wu H.-Y.; Tien C.-M.; MING-JU CHEN | Handbook of Animal-Based Fermented Food and Beverage Technology: Second Edition | 0 | ||
| 2014 | Combining secondary-structure and protein solvent-accessibility predictions in methionine substitution for anomalous dispersion | Wu H.-Y.; Cheng Y.-S. | Acta Crystallographica Section F:Structural Biology Communications | 4 | 3 | |
| 2017 | Comparative effectiveness of angiotensinconverting enzyme inhibitors versus angiotensin II receptor blockers for major renal outcomes in patients with diabetes: A 15-year cohort study | Wu H.-Y.; Peng C.-L.; Chen P.-C.; CHIH-KANG CHIANG ; Chang C.-J.; JENQ-WEN HUANG ; Peng Y.-S.; YU-KANG TU ; TZONG-SHINN CHU ; KUAN-YU HUNG ; KUO-LIONG CHIEN | PLoS ONE | 16 | 16 | |
| 2014 | Comparative effectiveness of antihypertensive drugs in patients with diabetes | Wu H.-Y.; KUAN-YU HUNG ; YU-KANG TU ; KUO-LIONG CHIEN | Journal of Comparative Effectiveness Research | 4 | 3 | |
| 2015 | Comparative Study of Outcomes among Patients with Polycystic Kidney Disease on Hemodialysis and Peritoneal Dialysis | Yang J.-Y.; Chen L.; CHIA-TER CHAO ; Peng Y.-S.; CHIH-KANG CHIANG ; Kao T.-W.; KUO-LIONG CHIEN ; Wu H.-Y.; JENQ-WEN HUANG ; KUAN-YU HUNG | Scientific Reports | 20 | 18 | |
| 2016 | A comparison of uremic pruritus in patients receiving peritoneal dialysis and hemodialysis | Wu H.-Y.; Peng Y.-S.; Chen H.-Y.; Tsai W.-C.; Yang J.-Y.; Hsu S.-P.; Pai M.-F.; Lu H.-M.; Chiang J.-F.; Ko M.-J.; Wen S.-Y.; HSIEN-CHING CHIU | Medicine (United States) | 37 | 33 | |
| 2022 | A comprehensive evaluation of COVID-19 policies and outcomes in 50 countries and territories | Tsou H.-H.; Kuo S.-C.; Lin Y.-H.; Hsiung C.A.; Chiou H.-Y.; WEI J. CHEN ; Wu S.-I.; Sytwu H.-K.; PAU-CHUNG CHEN ; Wu M.-H.; Hsu Y.-T.; Wu H.-Y.; Lee F.-J.; Shih S.-M.; Liu D.-P.; SHAN-CHWEN CHANG | Scientific Reports | 13 | 10 | |
| 2010 | Consensus Statement on the Adherence to Clinical and Laboratory Standards Institute (CLSI) Antimicrobial Susceptibility Testing Guidelines (CLSI-2010 and CLSI-2010-update) for Enterobacteriaceae in Clinical Microbiology Laboratories in Taiwan | PO-REN HSUEH ; Ko W.-C.; Wu J.-J.; Lu J.-J.; Wang F.-D.; Wu H.-Y.; Wu T.-L.; LEE-JENE TENG | Journal of Microbiology, Immunology and Infection | 73 | 68 | |
| 2013 | CYP1A2 genetic polymorphisms are associated with early antidepressant escitalopram metabolism and adverse reactions | Kuo H.-W.; Liu S.C.; Tsou H.-H.; Liu S.-W.; Lin K.-M.; SHAO-CHUN LU ; Hsiao M.-C.; Hsiao C.-F.; Liu C.-Y.; Chen C.-H.; Lu M.-L.; Shen W.W.; Tang H.-S.; Liu S.-I.; Chang L.-H.; Wu H.-Y.; Chang Y.-S.; Yeh T.-K.; Chen A.C.; Liu Y.-L. | Pharmacogenomics | 21 | 16 | |
| 2011 | CYP2B6 polymorphisms influence the plasma concentration and clearance of the methadone S-enantiomer | Wang S.-C.; Ho I.-K.; Tsou H.-H.; Tian J.-N.; Hsiao C.-F.; Chen C.-H.; Tan H.K.-L.; Lin L.; CHI-SHIN WU ; Su L.-W.; Huang C.-L.; Yang Y.-H.; Liu M.-L.; Lin K.-M.; Chen C.-Y.; Liu S.C.; Wu H.-Y.; Chan H.-W.; Tsai M.-H.; Lin P.-S.; Liu Y.-L. | Journal of Clinical Psychopharmacology | 69 | 60 | |
| 2016 | Diagnostic performance of attenuation-corrected myocardial perfusion imaging for coronary artery disease: A systematic review and meta-analysis | JEI-YIE HUANG ; CHUN-KAI HUANG ; RUOH-FANG YEN ; Wu H.-Y.; YU-KANG TU ; MEI-FANG CHENG ; CHING-CHU LU ; KAI-YUAN TZEN ; KUO-LIONG CHIEN ; YEN-WEN WU | Journal of Nuclear Medicine | 42 | 39 |
